Hjem › Orofaryngeal kreft › Illinois
Kliniske studier for Orofaryngeal kreft i Illinois
8 studier for Orofaryngeal kreft søker deltakere på steder i Illinois.
Byer i Illinois
- Chicago7 studier
- Naperville4 studier
- Danville3 studier
- Charleston3 studier
- Champaign3 studier
- Aurora3 studier
- Bloomington3 studier
- Galesburg3 studier
- Peoria3 studier
- North Peoria3 studier
- Joliet3 studier
Offisiell studietekst (engelsk)
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Rush MD Anderson Cancer Center, Chicago
- Carle at The Riverfront, Danville
- Carle Physician Group-Effingham, Effingham
- og 4 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07195734BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Rush-Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- og 38 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
- Northwestern University, Chicago
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05172245Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- og 21 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- og 22 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07441681Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
- Northwestern University, Chicago
- Northwestern Medicine Warrenville, Warrenville
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT07178301Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. feb. 2026 · NCT07290621Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.